Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.
Hernández-Cruz B, Otero-Varela L, Freire-González M, Busquets-Pérez N, García González AJ, Moreno-Ramos M, Blanco-Madrigal JM, Manrique-Arija S, Perez-Pampin E, Ruiz-Montesino D, Sánchez-Alonso F, Sanchez-Piedra C, Castrejón I; BIOBADASER Study Group. Hernández-Cruz B, et al. Among authors: ruiz montesino d. Ann Rheum Dis. 2024 Aug 27;83(9):1189-1199. doi: 10.1136/ard-2023-225271. Ann Rheum Dis. 2024. PMID: 38594056 Free article.
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
Calvo-Gutiérrez J, López-Medina C, Otero-Varela L, Escudero-Contreras A, Ortega-Castro R, Ladehesa-Pineda L, Campos C, Bernabeu-Gonzalvez P, Pérez-Gómez A, García-Dorta A, Ruiz-Montesino D, Pombo-Suarez M, Ros-Vilamajo I, Sánchez-Alonso F, Castrejón I. Calvo-Gutiérrez J, et al. Among authors: ruiz montesino d. Arthritis Res Ther. 2024 Feb 23;26(1):57. doi: 10.1186/s13075-024-03287-9. Arthritis Res Ther. 2024. PMID: 38395899 Free PMC article.
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.
Exposito L, Sánchez-Piedra C, Vela-Casasempere P, Moreno-Ramos MJ, Campos C, Bohorquez C, Manero J, Calvo-Gutiérrez J, Rodríguez-Lozano C, Ruiz-Montesino D, Busquets N, García-González J, Castrejón I, Alonso F, Bustabad S, Díaz-González F. Exposito L, et al. Among authors: ruiz montesino d. Eur J Clin Invest. 2024 Feb;54(2):e14095. doi: 10.1111/eci.14095. Epub 2023 Sep 16. Eur J Clin Invest. 2024. PMID: 37715584
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry.
Pombo-Suárez M, Sanchez-Piedra C, Ruiz-Montesino D, Diaz-Torne C, Jovaní V, Cea-Calvo L, Castrejón I. Pombo-Suárez M, et al. Among authors: ruiz montesino d. Musculoskeletal Care. 2022 Jun;20(2):403-407. doi: 10.1002/msc.1595. Epub 2021 Oct 19. Musculoskeletal Care. 2022. PMID: 34668303 No abstract available.
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.
Sánchez-Piedra C, Sueiro-Delgado D, García-González J, Ros-Vilamajo I, Prior-Español A, Moreno-Ramos MJ, Garcia-Magallon B, Calvo-Gutiérrez J, Perez-Vera Y, Martín-Domenech R, Ruiz-Montesino D, Vela-Casasempere P, Expósito L, Sánchez-Alonso F, González-Davila E, Díaz-González F. Sánchez-Piedra C, et al. Among authors: ruiz montesino d. Sci Rep. 2021 Jul 23;11(1):15051. doi: 10.1038/s41598-021-94504-x. Sci Rep. 2021. PMID: 34302036 Free PMC article.